BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37532904)

  • 21. Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence.
    Huang Y; Yang X; Zhao F; Shen Q; Wang Z; Lv X; Hu B; Yu B; Fan J; Qin W
    Med Oncol; 2014 Jul; 31(7):966. PubMed ID: 24878698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
    Kornberg A; Schernhammer M; Kornberg J; Friess H; Thrum K
    Dig Dis Sci; 2019 Jan; 64(1):269-280. PubMed ID: 30259282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
    Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
    Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late recurrence of hepatocellular carcinoma after liver transplantation: is an active surveillance for recurrence needed?
    Castroagudín JF; Molina-Pérez E; Ferreiro-Iglesias R; Abdulkader I; Otero-Antón E; Tomé S; Varo-Pérez E
    Transplant Proc; 2012; 44(6):1565-7. PubMed ID: 22841215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follow-up Imaging After Liver Transplantation Should Take Into Consideration Primary Hepatocellular Carcinoma Characteristics.
    Dioguardi Burgio M; Ronot M; Fuks D; Dondero F; Cauchy F; Gaujoux S; Dokmak S; Paradis V; Durand F; Belghiti J; Vilgrain V
    Transplantation; 2015 Aug; 99(8):1613-8. PubMed ID: 25710611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.
    Imura S; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Saito Y; Iwahashi S; Ikemoto T; Morine Y; Shimada M
    Int J Clin Oncol; 2018 Feb; 23(1):98-103. PubMed ID: 28875240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
    Jiang Z; Jiang Q; Fang X; Wang P; Que W; Li H; Yu Y; Liu X; Wang C; Zhong L
    BMC Cancer; 2021 May; 21(1):521. PubMed ID: 33964921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma].
    Wang J; He BJ; Jiang ZB; Zhang YQ; Shan H; Xiao R; Zhang JS; Luo L; Kuang SC; Chen GH; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):691-6. PubMed ID: 20021867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma.
    Tan CK; Gores GJ; Steers JL; Porayko MK; Hay JE; Rakela J; Wiesner RH; Krom RA
    Mayo Clin Proc; 1994 Jun; 69(6):509-14. PubMed ID: 7514702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection.
    Eguchi S; Takatsuki M; Hidaka M; Soyama A; Tomonaga T; Muraoka I; Kanematsu T
    World J Surg; 2010 May; 34(5):1034-8. PubMed ID: 20127241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.
    Mehta N; Heimbach J; Harnois DM; Sapisochin G; Dodge JL; Lee D; Burns JM; Sanchez W; Greig PD; Grant DR; Roberts JP; Yao FY
    JAMA Oncol; 2017 Apr; 3(4):493-500. PubMed ID: 27838698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for hepatocellular carcinoma recurrence: experience with 83 liver transplantation patients.
    Ataide EC; Boin IF; Almeida JR; Sevá-Pereira T; Stucchi RS; Cardoso AR; Caruy CA; Escanhoela CA
    Transplant Proc; 2011 May; 43(4):1362-4. PubMed ID: 21620130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B viral infection.
    Pei F; Shang K; Jiang B; Wang H; Mei F; Zhang Y; Du J; Zhong H; You J
    Hepatol Int; 2013 Jun; 7(2):468-76. PubMed ID: 26201779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma.
    McHugh PP; Gilbert J; Vera S; Koch A; Ranjan D; Gedaly R
    HPB (Oxford); 2010 Feb; 12(1):56-61. PubMed ID: 20495646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of orthotopic liver transplantation for liver cirrhosis in the presence of incidental and/or undetected hepatocellular carcinoma and tumour characteristics.
    Adham M; Oussoultzoglou E; Ducerf C; Bancel B; Bizollon T; Rode A; Berthoux N; De La Roche E; Baulieux J
    Transpl Int; 1998; 11 Suppl 1():S197-200. PubMed ID: 9664978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection.
    Wu L; Hu A; Tam N; Zhang J; Lin M; Guo Z; He X
    PLoS One; 2012; 7(7):e41820. PubMed ID: 22848619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis.
    Renzulli M; Buonfiglioli F; Conti F; Brocchi S; Serio I; Foschi FG; Caraceni P; Mazzella G; Verucchi G; Golfieri R; Andreone P; Brillanti S
    Eur Radiol; 2018 Feb; 28(2):506-513. PubMed ID: 28894901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.